Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study.
Saved in:
| Title: | Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study. |
|---|---|
| Authors: | Johnson ML; Department of Medical Oncology, Sarah Cannon Cancer Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee. Electronic address: Melissa.Johnson@sarahcannon.com., Zvirbule Z; Latvian Oncology Centre, Riga East University Hospital, Riga, Latvia., Laktionov K; Federal State Budgetary Institution 'N.N.Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Moscow, Russia., Helland A; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway., Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Gutierrez V; Department of Medical Oncology, Hospital Regional Universitario de Málaga, Málaga, Spain., Colinet B; Department of Pneumology, Grand Hôpital de Charleroi, Charleroi, Belgium., Lena H; Centre Hospitalier Universitaire, Rennes, Hospital de Pontchaillou, France; INSERM U 1242, Université Rennes 1, Rennes, France., Wolf M; Department of Hematology and Oncology, Klinikum Kassel Hospital, Kassel, Germany., Gottfried M; Department of Oncology, Meir Medical Center, Kfar Saba, Israel., Okamoto I; Department of Medical Oncology, Kyushu University Hospital, Fukuoka, Japan., van der Leest C; Department of Pulmonology, Amphia Ziekenhuis, Breda, the Netherlands., Rich P; Department of Medical Oncology, Cancer Treatment Centers of America, Newnan, Georgia., Hung JY; Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan., Appenzeller C; Division of Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland., Sun Z; AbbVie, Inc, North Chicago, Illinois., Maag D; AbbVie, Inc, North Chicago, Illinois., Luo Y; AbbVie, Inc, North Chicago, Illinois., Nickner C; AbbVie, Inc, North Chicago, Illinois., Vajikova A; AbbVie, Inc, North Chicago, Illinois., Komarnitsky P; AbbVie, Inc, North Chicago, Illinois., Bar J; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel; Sackler Medical School, Tel-Aviv University, Tel-Aviv, Israel. |
| Source: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2021 Sep; Vol. 16 (9), pp. 1570-1581. Date of Electronic Publication: 2021 Apr 03. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33823285 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Johnson+ML%22">Johnson ML</searchLink>; Department of Medical Oncology, Sarah Cannon Cancer Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee. Electronic address: Melissa.Johnson@sarahcannon.com.<br /><searchLink fieldCode="AU" term="%22Zvirbule+Z%22">Zvirbule Z</searchLink>; Latvian Oncology Centre, Riga East University Hospital, Riga, Latvia.<br /><searchLink fieldCode="AU" term="%22Laktionov+K%22">Laktionov K</searchLink>; Federal State Budgetary Institution 'N.N.Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Moscow, Russia.<br /><searchLink fieldCode="AU" term="%22Helland+A%22">Helland A</searchLink>; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Cho+BC%22">Cho BC</searchLink>; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Gutierrez+V%22">Gutierrez V</searchLink>; Department of Medical Oncology, Hospital Regional Universitario de Málaga, Málaga, Spain.<br /><searchLink fieldCode="AU" term="%22Colinet+B%22">Colinet B</searchLink>; Department of Pneumology, Grand Hôpital de Charleroi, Charleroi, Belgium.<br /><searchLink fieldCode="AU" term="%22Lena+H%22">Lena H</searchLink>; Centre Hospitalier Universitaire, Rennes, Hospital de Pontchaillou, France; INSERM U 1242, Université Rennes 1, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Wolf+M%22">Wolf M</searchLink>; Department of Hematology and Oncology, Klinikum Kassel Hospital, Kassel, Germany.<br /><searchLink fieldCode="AU" term="%22Gottfried+M%22">Gottfried M</searchLink>; Department of Oncology, Meir Medical Center, Kfar Saba, Israel.<br /><searchLink fieldCode="AU" term="%22Okamoto+I%22">Okamoto I</searchLink>; Department of Medical Oncology, Kyushu University Hospital, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22van+der+Leest+C%22">van der Leest C</searchLink>; Department of Pulmonology, Amphia Ziekenhuis, Breda, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Rich+P%22">Rich P</searchLink>; Department of Medical Oncology, Cancer Treatment Centers of America, Newnan, Georgia.<br /><searchLink fieldCode="AU" term="%22Hung+JY%22">Hung JY</searchLink>; Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Appenzeller+C%22">Appenzeller C</searchLink>; Division of Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sun+Z%22">Sun Z</searchLink>; AbbVie, Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Maag+D%22">Maag D</searchLink>; AbbVie, Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Luo+Y%22">Luo Y</searchLink>; AbbVie, Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Nickner+C%22">Nickner C</searchLink>; AbbVie, Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Vajikova+A%22">Vajikova A</searchLink>; AbbVie, Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Komarnitsky+P%22">Komarnitsky P</searchLink>; AbbVie, Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Bar+J%22">Bar J</searchLink>; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel; Sackler Medical School, Tel-Aviv University, Tel-Aviv, Israel. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101274235%22">Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer</searchLink> [J Thorac Oncol] 2021 Sep; Vol. 16 (9), pp. 1570-1581. <i>Date of Electronic Publication: </i>2021 Apr 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101274235 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1556-1380 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215560864%22">15560864 </searchLink><i>NLM ISO Abbreviation: </i>J Thorac Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33823285 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jtho.2021.03.012 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1570 Titles: – TitleFull: Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Johnson ML – PersonEntity: Name: NameFull: Zvirbule Z – PersonEntity: Name: NameFull: Laktionov K – PersonEntity: Name: NameFull: Helland A – PersonEntity: Name: NameFull: Cho BC – PersonEntity: Name: NameFull: Gutierrez V – PersonEntity: Name: NameFull: Colinet B – PersonEntity: Name: NameFull: Lena H – PersonEntity: Name: NameFull: Wolf M – PersonEntity: Name: NameFull: Gottfried M – PersonEntity: Name: NameFull: Okamoto I – PersonEntity: Name: NameFull: van der Leest C – PersonEntity: Name: NameFull: Rich P – PersonEntity: Name: NameFull: Hung JY – PersonEntity: Name: NameFull: Appenzeller C – PersonEntity: Name: NameFull: Sun Z – PersonEntity: Name: NameFull: Maag D – PersonEntity: Name: NameFull: Luo Y – PersonEntity: Name: NameFull: Nickner C – PersonEntity: Name: NameFull: Vajikova A – PersonEntity: Name: NameFull: Komarnitsky P – PersonEntity: Name: NameFull: Bar J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2021 Sep Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1556-1380 Numbering: – Type: volume Value: 16 – Type: issue Value: 9 Titles: – TitleFull: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Type: main |
| ResultId | 1 |
